Skip to main content
Skip to content
Case File
sd-10-EFTA01354020Dept. of JusticeOther

EFTA Document EFTA01354020

GLDUS183 Dimension Capri& Management SOF IV — Project Klein Exclusive deal El Fund Secondary Secondary K Single Asset Deal Expected Glosing Date: June 2018 Seller type: Alternative funds Key investment data Transaction summary Invested Capital at dose E60-100m (US$80-120m) Number of companies 4 Discount to NAV at close >5% Strategy Mid-market buyout Gross multiple at close 1.1x Region Europe / UK 0/0 funded at close 80% Industries Business services / Healthcare servic

Date
Unknown
Source
Dept. of Justice
Reference
sd-10-EFTA01354020
Pages
1
Persons
0
Integrity
Loading PDF viewer...

Summary

GLDUS183 Dimension Capri& Management SOF IV — Project Klein Exclusive deal El Fund Secondary Secondary K Single Asset Deal Expected Glosing Date: June 2018 Seller type: Alternative funds Key investment data Transaction summary Invested Capital at dose E60-100m (US$80-120m) Number of companies 4 Discount to NAV at close >5% Strategy Mid-market buyout Gross multiple at close 1.1x Region Europe / UK 0/0 funded at close 80% Industries Business services / Healthcare servic

Ask AI About This Document

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
GLDUS183 Dimension Capri& Management SOF IV — Project Klein Exclusive deal El Fund Secondary Secondary K Single Asset Deal Expected Glosing Date: June 2018 Seller type: Alternative funds Key investment data Transaction summary Invested Capital at dose E60-100m (US$80-120m) Number of companies 4 Discount to NAV at close >5% Strategy Mid-market buyout Gross multiple at close 1.1x Region Europe / UK 0/0 funded at close 80% Industries Business services / Healthcare services Use of leverage No Average age at purchase 9 years Description - Motivated quality GP aiming to recapitalize and extend their 2007 mid- market pan-European fund while providing liquidity to LPs - Key value driver is largest independent UK premium distributor in its segment, well positioned to benefit from market tailwinds - Second largest asset is a network of medical and cosmetics UK clinics with a private and affluent customer base - The portfolio also includes an Italian digital marketing company and a management consulting company with blue chip customers - Glendower Capital retains discretion on use of follow-on capital Investment rationale / Glendower Team angle Glendower Team angle - Ability to quickly deliver a bespoke solution leveraging Glendower's track record in complex transactions - Ability to perform extensive diligence, including onsite visits, full access to companies' management and industry specialists - Long 15-year relationship with the GP founder Investment rationale - Four well-invested companies positioned to capture growth opportunities arising from ongoing changes in industry landscape - Key value driver led by industry veteran with a solid track record - Value-add potential from recently implemented cost efficiency initiatives - Opportunity to invest in identified follow-ons at closing, and to contribute additional capita! to exploit market dislocations —':ot disckm.sSon perposesr4y. The investment pjeserged above I . s. tme sect the is no scuatsincee that etc., itstestineot crai.ripliÅe or !Of fl‘ part og si Icgure irivasted pottfcCio that g *di be aitaiistge or. aftec furt1wi due diligence., prove sultet,» for :1‘.0F This. slide hauld be mod and tevle-wc-d in conjunetion with the 'Important Information and "Important Performance Inforrnabon and • Notes to Investment Pene/mens° sections. Glendower Capita! STRICTLY CONFIDENTIAL 41 C0NFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0038612 CONFIDENTIAL SDNY_GM_00184796 EFTA01354020

Related Documents (6)

Dept. of JusticeOtherUnknown

EFTA Document EFTA01382731

S- I/A Table of Contents Perquisite and Personal Benefits Tax Financial Defined Contribution Life Insurance Gross-lip Payments Severance Payments Relocation Benefits Other Compensation Total Name Blanninu(S) Plain(S) (IXS) (2)(S) (3XS) OBS) (5)(S) (5) Frank l. Bisignano 18.812 265 4.902 270,017 — 52,384 186.819 533,199 Michael K. bleborak — — 1.183 — — — — 1.183 Ray E. Winbomc — 984 1.683 2.085,768 - - 2,088.435 Cynthia A. Armine-Klein — 673

1p
OtherUnknown

NAME SEARCHED: Jeffrey Epstein

DOJ EFTA Data Set 10 document EFTA01296720

114p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01268970

1First Bank Customer Due D...gence for Business - Entities ExtednerAtiiialiS-- I $7;41=-6-- Business or Entity name: Thomas 'Maid Air, LLC DEA Name (lt applicable) Physical Add .: 8203 Lindberg Be, SUMO 33 Si. Thomas, VI 170802 Business Phone: 340-775.2525 2. BusinessrEnto Desert Tyro ol Buelnees. Date F_stablishedr. Type of Entity • or Social Security /amber Social Security Number (If applicable): ramp Address: 6100 Red Hook Duarte( B3 SI. Thomas USV1. 00802 Fax Email

130p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01389964

GLDUS132 EverWatch Financial SOF IV — Project Klein Exclusive deal Expected Glosing Date: June 2018 El Fund Secondary StreGP-led Secondary K Single Anet Deal Seller type: Alternative funds Key investment data Transaction summary Invested Capital at dose E60-100m (US$80-120m) Number of companies 4 Discount to NAV at close >5% Strategy Mid-market buyout Gross multiple at close 1.1x Region Europe / UK 0/0 funded at close 80% Industries Business services / Healthcare serv

1p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01364547

GLOUS238 SOUTHERN FINANCIAL LLC SOF IV — Project Klein Exclusive deal Expected Glosing Date: June 2018 El Fund Secondary i Secondary K Single Asset Deal Seller type: Alternative funds Key investment data Transaction summary Invested Capital at dose E60-100m (US$80-120m) Number of companies 4 Discount to NAV at close >5% Strategy Mid-market buyout Gross multiple at close 1.1x Region Europe / UK 0/0 funded at close 80% Industries Business services / Healthcare services

1p
Dept. of JusticeOtherUnknown

EFTA Document EFTA01391879

GLDUS142 Ironsides Assel Mgmt SOF IV — Project Klein Exclusive deal Expected Glosing Date: June 2018 El Fund Secondary i Secondary K Single Asset Deal Seller type: Alternative funds Key investment data Transaction summary Invested Capital at dose E60-100m (US$80-120m) Number of companies 4 Discount to NAV at close >5% Strategy Mid-market buyout Gross multiple at close 1.1x Region Europe / UK 0/0 funded at close 80% Industries Business services / Healthcare services Us

1p

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.